Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

The 50th Annual Meeting of the European Society for Blood and Marrow Transplantation (EBMT) was held in Glasgow, Scotland, and online, on 14-17 April, 2024. This meeting brought together clinicians, researchers, nurses, and patients, who discussed the latest updates in the field of blood and marrow transplantation and cellular therapies.
View all videos

EBMT 2024

The 50th Annual Meeting of the EBMT
14–17 April 2024 | Glasgow, Scotland

EBMT 2024

The 50th Annual Meeting of the EBMT
14–17 April 2024 | Glasgow, Scotland
The 50th Annual Meeting of the European Society for Blood and Marrow Transplantation (EBMT) was held in Glasgow, Scotland, and online, on 14-17 April, 2024. This meeting brought together clinicians, researchers, nurses, and patients, who discussed the latest updates in the field of blood and marrow transplantation and cellular therapies.
View all videos

Latest Videos

View all videos
2:05
CAR T-cell therapy programs to improve access for patients with leukemia in Mexico
Alberto Olaya-Vargas • 15 Apr 2024
14:43
Current research into post-alloSCT maintenance therapy in AML
Ali Bazarbachi • 3 May 2024
4:09
Veno-occlusive disease as a post-transplant complication of HSCT
Mohamad Mohty • 17 Apr 2024
10:31
Comparing haploSCT to other donor types in lymphoma treatment
Ali Bazarbachi • 3 May 2024

Lymphoma

View all
10:31
Comparing haploSCT to other donor types in lymphoma treatment
Ali Bazarbachi • 3 May 2024
2:39
The role of bispecific antibodies in the treatment landscape for R/R DLBCL
Wendy Osborne • 22 Apr 2024

Leukemia

View all
2:05
CAR T-cell therapy programs to improve access for patients with leukemia in Mexico
Alberto Olaya-Vargas • 15 Apr 2024
14:43
Current research into post-alloSCT maintenance therapy in AML
Ali Bazarbachi • 3 May 2024

Transplantation

View all
14:43
Current research into post-alloSCT maintenance therapy in AML
Ali Bazarbachi • 3 May 2024
4:09
Veno-occlusive disease as a post-transplant complication of HSCT
Mohamad Mohty • 17 Apr 2024

CAR-T

View all
2:05
CAR T-cell therapy programs to improve access for patients with leukemia in Mexico
Alberto Olaya-Vargas • 15 Apr 2024
5:20
Targeted therapies in AML: menin, FLT3 and IDH inhibitors
Felicitas Thol • 19 Apr 2024

Choose your cookie settings

VJHemOnc uses necessary cookies to make the site work. With your permission we'd also like to use analytics, preference and marketing cookies to understand how the site is used and improve it.

Choose an option to continue. You can change it at any time on our Cookie Policy page, linked at the bottom of every page.

Cookie Policy (opens in a new tab)
The content of VJHemOnc is intended for healthcare professionals